Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?

被引:56
作者
Finlay, B. Brett [1 ,2 ,3 ]
Goldszmid, Romina [4 ]
Honda, Kenya [5 ,6 ]
Trinchieri, Giorgio [7 ]
Wargo, Jennifer [8 ,9 ]
Zitvogel, Laurence [10 ,11 ,12 ,13 ]
机构
[1] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada
[3] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada
[4] NCI, Inflammatory Cell Dynam Sect, Lab Integrat Canc Immunol, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
[5] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan
[6] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan
[7] NCI, Canc Lmmunobiol Sect, Lab Integrat Canc Immunol, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
[8] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Div Canc Med, Houston, TX 77030 USA
[9] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Div Surg, Houston, TX 77030 USA
[10] Paris Saclay Univ, Fac Med, Le Kremlin Bicetre, France
[11] Gustave Roussy Comprehens Canc Ctr, Villejuif, France
[12] INSERM U1015, Villejuif, France
[13] Ctr Clin Invest Biotherapies Canc, F-1428 Villejuif, France
基金
美国国家卫生研究院; 欧盟地平线“2020”; 欧洲研究理事会;
关键词
GUT; BACTERIA; IMMUNITY; PROBIOTICS; IMPACT;
D O I
10.1038/s41577-020-0374-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this Viewpoint, six leading experts consider the ways in which the microbiota can influence immune responses to cancer. Immunotherapies have been revolutionary in the treatment of cancer, but will we one day further increase their efficacy with microbiota-derived drugs? There is currently much interest in defining how the microbiota shapes immune responses in the context of cancer. Various studies in both mice and humans have associated particular commensal species with better (or worse) outcomes in different cancer types and following treatment with cancer immunotherapies. However, the mechanisms involved remain ill-defined and even controversial. In this Viewpoint,Nature Reviews Immunologyhas invited six eminent scientists in the field to share their thoughts on the key questions and challenges for the field. The contributors B. Brett Finlay is a professor in the Michael Smith Laboratories at the University of British Columbia. His research interests are focused on host-microorganism interactions, at the molecular level, and he has published more than 500 articles. He is a co-author of the booksLet Them Eat DirtandThe Whole-Body Microbiome. Romina Goldszmid is an Earl Stadtman Investigator and Head of the Inflammatory Cell Dynamics Section in the Laboratory of Integrative Cancer Immunology, National Cancer Institute, National Institutes of Health (NIH). She received her PhD degree from the University of Buenos Aires, Argentina, and completed her postdoctoral training at the National Institute of Allergy and Infectious Diseases, NIH. She has a long-standing interest in understanding myeloid cell development, differentiation and function in the context of cancer and infections. Current work in her laboratory aims to dissect the myeloid cell repertoire within tumours, determine their contribution to therapy efficacy and unravel the mechanisms by which the microbiota regulates their function. Kenya Honda is a professor at Keio University School of Medicine and a team leader at the RIKEN Center for Integrative Medical Sciences, Japan. His laboratory has been aiming to elucidate and translate the mutualistic relationship between the gut microbiota and the host immune system using gnotobiotic animal models. Giorgio Trinchieri is an NIH Distinguished Investigator and Chief of the Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, NIH. His research has focused for many years on the interplay between inflammation, innate resistance and adaptive immunity and on the role of pro-inflammatory cytokines and interferons in the regulation of haematopoiesis, innate resistance and immunity against infections and tumours. The present focus of his laboratory is on the role of inflammation, innate resistance, immunity and the commensal microbiota in carcinogenesis, cancer progression and prevention of or therapy for cancer. Jennifer Wargo is a professor of surgical oncology and genomic medicine at the University of Texas MD Anderson Cancer Center. She leads the Program for Innovative Microbiome and Translational Research (PRIME-TR) and is internationally recognized for her contributions to cancer research in immunotherapy and the microbiome. Laurence Zitvogel, full professor at Paris-Saclay University, is a research director at INSERM and Scientific Director of the immuno-oncology program at Gustave Roussy, France. She has contributed to the field of cancer immunology and immunotherapy, pioneering the concepts of immunogenic cell death and gut microbiota in cancer.
引用
收藏
页码:522 / 528
页数:7
相关论文
共 55 条
  • [1] Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy
    Anker, Jonathan F.
    Naseem, Anum F.
    Mok, Hanlin
    Schaeffer, Anthony J.
    Abdulkadir, Sarki A.
    Thumbikat, Praveen
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [2] VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer
    Arthur, Janelle C.
    Gharaibeh, Raad Z.
    Uronis, Joshua M.
    Perez-Chanona, Ernesto
    Sha, Wei
    Tomkovich, Sarah
    Muehlbauer, Marcus
    Fodor, Anthony A.
    Jobin, Christian
    [J]. SCIENTIFIC REPORTS, 2013, 3
  • [3] Fecal microbiota transplantation (FMT) and re-induction of anti-PD-1 therapy in refractory metastatic melanoma patients - preliminary results from a phase I clinical trial (NCT03353402)
    Baruch, Erez N.
    Youngster, Ilan
    Ortenberg, Rona
    Ben-Betzalel, Guy
    Katz, Lior H.
    Lahat, Adi
    Barshack, Iris
    Dick-Necula, Daniela
    Mamtani, Ronac
    Bloch, Naamah
    Ungar, Bella
    Rotin, Daniel
    Avivi, Camila
    Anafi, Liat
    Steinberg-Silman, Yael
    Asher, Nethanel
    Shapira-Frommer, Ronnie
    Brosh-Nissimov, Tal
    Eshet, Yael
    Raskin, Stephen
    Harati, Hagit
    MeInichenko, Jenny
    Schachter, Jacob
    Koren, Omry
    Markel, Gal
    Boursi, Ben
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [4] Batten M, 2019, CANCER RES, DOI [10.1158/1538-7445.AM2019-2822, DOI 10.1158/1538-7445.AM2019-2822]
  • [5] The Role of the Microbiome in Cancer Development and Therapy
    Bhatt, Aadra P.
    Redinbo, Matthew R.
    Bultman, Scott J.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (04) : 327 - 344
  • [6] Chalabi M, 2020, ANN ONCOL, V31, P525, DOI [10.1016/j.annoc.2020.01.006, 10.1016/j.annonc.2020.01.006]
  • [7] Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
    Derosa, L.
    Hellmann, M. D.
    Spaziano, M.
    Halpenny, D.
    Fidelle, M.
    Rizvi, H.
    Long, N.
    Plodkowski, A. J.
    Arbour, K. C.
    Chaft, J. E.
    Rouche, J. A.
    Zitvogel, L.
    Zalcman, G.
    Albiges, L.
    Escudier, B.
    Routy, B.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (06) : 1437 - 1444
  • [8] The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?
    Elkrief, A.
    Derosa, L.
    Kroemer, G.
    Zitvogel, L.
    Routy, B.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 (10) : 1572 - 1579
  • [9] Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
    Geller, Leore T.
    Barzily-Rokni, Michal
    Danino, Tal
    Jonas, Oliver H.
    Shental, Noam
    Nejman, Deborah
    Gavert, Nancy
    Zwang, Yaara
    Cooper, Zachary A.
    Shee, Kevin
    Thaiss, Christoph A.
    Reuben, Alexandre
    Livny, Jonathan
    Avraham, Roi
    Frederick, Dennie T.
    Ligorio, Matteo
    Chatman, Kelly
    Johnston, Stephen E.
    Mosher, Carrie M.
    Brandis, Alexander
    Fuks, Garold
    Gurbatri, Candice
    Gopalakrishnan, Vancheswaran
    Kim, Michael
    Hurd, Mark W.
    Katz, Matthew
    Fleming, Jason
    Maitra, Anirban
    Smith, David A.
    Skalak, Matt
    Bu, Jeffrey
    Michaud, Monia
    Trauger, Sunia A.
    Barshack, Iris
    Golan, Talia
    Sandbank, Judith
    Flaherty, Keith T.
    Mandinova, Anna
    Garrett, Wendy S.
    Thayer, Sarah P.
    Ferrone, Cristina R.
    Huttenhower, Curtis
    Bhatia, Sangeeta N.
    Gevers, Dirk
    Wargo, Jennifer A.
    Golub, Todd R.
    Straussman, Ravid
    [J]. SCIENCE, 2017, 357 (6356) : 1156 - +
  • [10] Microbiota and cancer immunotherapy: in search of microbial signals
    Gharaibeh, Raad Z.
    Jobin, Christian
    [J]. GUT, 2019, 68 (03) : 385 - 388